Abstract
ABSTRACT The early host response is critical for protection against viral infections, yet the systemic events that dictate individual differences in outcomes remain poorly defined. Here, we leveraged variability in survival following intranasal vesicular stomatitis virus (VSV) challenge in genetically identical mice to retrospectively profile systemic immune responses associated with survival or lethality. Survival was strongly associated with a robust systemic type I interferon (IFN) surge within 24 hours of infection, and blockade of type I IFN signaling during this narrow early window markedly reduced survival, establishing early IFN induction as a key determinant of outcome. This protective IFN surge rapidly remodeled the systemic immune landscape. Single-cell profiling revealed a transcriptionally and functionally distinct ICAM1⁺ neutrophil subset as the strongest early correlate of survival, primed within the bone marrow. ICAM1⁺ neutrophils exhibited a pro-inflammatory signature and enhanced phagocytic activity compared with ICAM1⁻ neutrophils, which predominated in lethal outcomes. Together, these findings define a type I IFN–driven early checkpoint that governs survival in lethal viral infection and identify ICAM1⁺ neutrophils as a blood-accessible biomarker of protective immunity, highlighting the critical role of early innate immune dynamics in shaping disease trajectories and providing a framework for early prognostic markers and host-directed therapies.
Full text
1,567 characters
· extracted from
oa-doi-fallback
· click to expand
ABSTRACT
The early host response is critical for protection against viral infections, yet the systemic events that dictate individual differences in outcomes remain poorly defined. Here, we leveraged variability in survival following intranasal vesicular stomatitis virus (VSV) challenge in genetically identical mice to retrospectively profile systemic immune responses associated with survival or lethality. Survival was strongly associated with a robust systemic type I interferon (IFN) surge within 24 hours of infection, and blockade of type I IFN signaling during this narrow early window markedly reduced survival, establishing early IFN induction as a key determinant of outcome. This protective IFN surge rapidly remodeled the systemic immune landscape. Single-cell profiling revealed a transcriptionally and functionally distinct ICAM1⁺ neutrophil subset as the strongest early correlate of survival, primed within the bone marrow. ICAM1⁺ neutrophils exhibited a pro-inflammatory signature and enhanced phagocytic activity compared with ICAM1⁻ neutrophils, which predominated in lethal outcomes. Together, these findings define a type I IFN–driven early checkpoint that governs survival in lethal viral infection and identify ICAM1⁺ neutrophils as a blood-accessible biomarker of protective immunity, highlighting the critical role of early innate immune dynamics in shaping disease trajectories and providing a framework for early prognostic markers and host-directed therapies.
Competing Interest Statement
The authors have declared no competing interest.
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.